Table 1 The clinical characteristics of 136 patients with advanced gastric cancer
| Characteristic |
Total n = 136 (%) | NLR | PLR | ||
|---|---|---|---|---|---|
| Mean ± SEM | P value | Mean ± SEM | P value | ||
| Gender | 0.876 | 0.115 | |||
| Male | 82 (60.3%) | 3.36 ± 0.30 | 191.66 ± 11.84 | ||
| Female | 54 (39.7%) | 3.43 ± 0.37 | 222.64 ± 16.00 | ||
| Age | 0.446 | 0.966 | |||
| ≤55 years | 74 (54.4%) | 3.55 ± 0.37 | 204.34 ± 12.45 | ||
| >55 years | 62 (45.6%) | 3.20 ± 0.24 | 203.51 ± 15.06 | ||
| Differentiation | 0.144 | 0.169 | |||
| Poor | 90 (66.2%) | 3.59 ± 0.32 | 213.43 ± 10.70 | ||
| Moderate/Well | 46 (33.8%) | 2.99 ± 0.25 | 185.44 ± 19.07 | ||
| Chemotherapy regimen | 0.158 | 0.964 | |||
| FOLFOX | 40 (29.4%) | 3.77 ± 0.52 | 209.31 ± 16.29 | ||
| CapeOX | 26 (19.1%) | 3.94 ± 0.70 | 200.37 ± 26.76 | ||
| TP | 21 (15.4%) | 3.58 ± 0.42 | 210.15 ± 22.98 | ||
| Others | 49 (36.1%) | 2.71 ± 0.22 | 198.85 ± 15.84 | ||